Bolt Biotherapeutics Inc. is a biotechnology company that focuses on developing and commercializing antibody-based therapies for the treatment of cancer. Their innovative approach utilizes immune-stimulating payloads to selectively activate the immune system and attack tumor cells. With a promising pipeline and a dedicated team, Bolt Biotherapeutics is poised to make a meaningful impact in the field of oncology.
Notification